Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout
Objective
To evaluate the efficacy, immunogenicity, and tolerability of intravenous (IV) PEGylated recombinant mammalian urate oxidase (PEG-uricase) for the treatment of severe gout.
Methods
Single infusions of PEG-uricase (at doses ranging from 0.5 mg to 12 mg) were administered to 24 patients (6 cohorts of 4 patients each) in a phase I clinical trial. Plasma uricase activity (pUox), the plasma urate concentration (pUAc), and the uric acid-to-creatinine ratio (UAc:Cr) in urine were monitored for 21 days after dosing. Adverse events and the IgG antibody response to PEG-uricase were followed up for 35 days.
Results
All patients completed the trial. Maximum pUox was linearly related to the IV dose of PEG-uricase, the area under the curve (AUC) value increased linearly (up to a dose of 8 mg), and the pUox half-life was 6.4-13.8 days. After doses of 4-12 mg, the pUAc fell within 24-72 hours, from a mean ± SD value of 11.1 ± 0.6 mg/dl to 1.0 ± 0.5 mg/dl; the AUC value for the pUAc was equivalent to maintaining the pUAc at 1.2-4.7 mg/dl for 21 days postinfusion. The UAc:Cr ratio in urine fell in parallel with the pUAc. IgG antibodies to PEG-uricase, mostly IgG2 and specific for PEG, developed in 9 patients, who had more rapid enzyme clearance but no allergic reactions. All adverse events were mild to moderate, with gout flares being most common.
Conclusion
The bioavailability, efficacy, and tolerability of IV PEG-uricase were greater than the bioavailability, efficacy, and tolerability observed in a previous phase I trial of subcutaneous PEG-uricase. Infusing 4-12 mg of PEG-uricase every 2-4 weeks should maintain the pUAc well below the therapeutic target of 6 mg/dl and greatly reduce renal uric acid excretion. This treatment could be effective in depleting expanded tissue urate stores in patients with chronic or tophaceous gout.
Los Angeles County Hospital
Monthly Paper Selection
Journal RSS (FEEDS):
By following the link below, you will be redirected to my Bloglines website. I set up a page with FEEDS from the main Rheumatology Journals, Internal Medicine Journals and Immunology Basic Science Journals:
http://www.bloglines.com/public/brunostoliver
In addition, I made available some FEEDS from Rheumatology Journals below, but be aware that this is not a complete list of each Journal issue. To get the complete list, click in the link above and you will be redirected to bloglines.com
Medscape Rheumatology Headlines
Physician's First Watch: Current Issue
Arthritis & Rheumatism
Annals of the Rheumatic Diseases current issue
Rheumatology - current issue
Current Opinion in Rheumatology - Current Table Of Contents
CER - Recent Issue
Arthritis Research & Therapy - Latest articles
JCR: Journal of Clinical Rheumatology - Current Table Of Contents
Nature Clinical Practice Rheumatology
Lupus current issue
Journal Links (Blogroll from Bloglines)
Rheumatology Journals Schedule
- Arthritis and Rheumatism: Monthly
- Annals of Rheumatic Disease (The EULAR Journal): Monthly
- Journal of Rheumatology: bi-weekly (only e-mail TOC/no RSS)
- Rheumatology (Oxford): Monthly
- Current Opinion in Rheumatology (COR): 6 issues/year (bi-monthly)
- Clinical and Experimental Rheumatology (CER): 6 issues/year (bi-monthly)
- Arthritis Research and Therapy: 6 issues/year (bi-monthly)
- Journal of Clinical Rheumatology: 6 issues/year (bi-monthly)
- Scandinavian Journal of Rheumatology: 6 issues/year (bi-monthly) !No issues since July 2006
- Rheumatic Disease Clinics of North America: (4-5 reviews/year): Receive e-mail TOC. No RSS.
- Seminars in Arthritis and Rheumatism: 6 issues/year (bi-monthly)+ 2 Supplements: Receive e-mail TOC. No RSS.
- Nature Clinical Practice Rheumatology: Monthly
- Lupus Journal: Monthly
Internal Medicine Journals Schedule
- Archives of Internal Medicine: Bi-weelky (Monday)
- Annals of Internal Medicine: No RSS available: Bi-weekly (Tuesday) (only e-mail TOC)
- JAMA: Weekly (Wednesday)
- NEJM: Weekly (Thursday)
- Lancet: Weekly (Friday)
- British Medical Journal: Weekly (Saturday)
Friday, March 23, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment